• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢稳态的肠道中心模型。

A Gut-Centric Model of Metabolic Homeostasis.

机构信息

Fractyl Health, Inc., Lexington, MA, USA.

Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, California.

出版信息

J Diabetes Sci Technol. 2022 Nov;16(6):1567-1574. doi: 10.1177/19322968211044523. Epub 2021 Oct 26.

DOI:10.1177/19322968211044523
PMID:34697950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9631542/
Abstract

Modern changes in diet and lifestyle have led to an explosion of insulin resistance and metabolic diseases around the globe which, if left unchecked, will become a principal driver of morbidity and mortality in the 21st century. The nature of the metabolic homeostatic shift within the body has therefore become a topic of considerable interest. While the gut has long been recognized as an acute nutrient sensor with signaling mechanisms to the other metabolic organs of the body, its role in regulating the body's metabolic status over longer periods of time has been underappreciated. Recent insights from bariatric surgery and intestinal nutrient stimulation experiments provide a window into the adaptive role of the intestinal mucosa in a foregut/hindgut metabolic balance model that helps to define metabolic parameters within the body-informing the metabolic regulation of insulin resistance versus sensitivity, hunger versus satiety, energy utilization versus energy storage, and protection from hypoglycemia versus protection from hyperglycemia. This intestinal metabolic balance model provides an intellectual framework with which to understand the distinct roles of proximal and distal intestinal segments in metabolic regulation. The model may also aid in the development of novel disease-modifying therapies that can correct the dysregulated metabolic signals from the intestine and stem the tide of metabolic diseases in society.

摘要

现代饮食和生活方式的变化导致了胰岛素抵抗和代谢性疾病在全球范围内的爆发,如果不加以控制,它们将成为 21 世纪发病率和死亡率的主要驱动因素。因此,体内代谢稳态变化的性质已成为一个相当引人关注的话题。尽管肠道长期以来一直被认为是急性营养传感器,具有向身体其他代谢器官发出信号的机制,但它在调节身体更长时间的代谢状态方面的作用一直被低估。减肥手术和肠道营养刺激实验的最新研究结果为肠道黏膜在一个前肠/后肠代谢平衡模型中的适应性作用提供了一个窗口,该模型有助于确定体内的代谢参数,从而告知胰岛素抵抗与敏感性、饥饿与饱腹感、能量利用与能量储存、低血糖保护与高血糖保护之间的代谢调节。这个肠道代谢平衡模型为理解近端和远端肠道段在代谢调节中的不同作用提供了一个智力框架。该模型还可能有助于开发新的疾病修正疗法,这些疗法可以纠正肠道失调的代谢信号,遏制代谢性疾病在社会中的蔓延。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9631542/00b6f484f8dc/10.1177_19322968211044523-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9631542/8f0bfe275ba8/10.1177_19322968211044523-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9631542/00b6f484f8dc/10.1177_19322968211044523-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9631542/8f0bfe275ba8/10.1177_19322968211044523-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92c1/9631542/00b6f484f8dc/10.1177_19322968211044523-fig2.jpg

相似文献

1
A Gut-Centric Model of Metabolic Homeostasis.代谢稳态的肠道中心模型。
J Diabetes Sci Technol. 2022 Nov;16(6):1567-1574. doi: 10.1177/19322968211044523. Epub 2021 Oct 26.
2
Hydrothermal Duodenal Mucosal Resurfacing: Role in the Treatment of Metabolic Disease.水热十二指肠黏膜重塑:在代谢性疾病治疗中的作用
Gastrointest Endosc Clin N Am. 2017 Apr;27(2):299-311. doi: 10.1016/j.giec.2016.12.002.
3
Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.减重和微创手术后肠肽的变化:与糖尿病缓解的关系。
Peptides. 2018 Feb;100:114-122. doi: 10.1016/j.peptides.2017.12.010.
4
Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery.减重手术后糖尿病缓解的肠和胃起源。
Curr Obes Rep. 2018 Jun;7(2):139-146. doi: 10.1007/s13679-018-0302-2.
5
Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.减重/代谢手术后糖尿病改善的机制。
Diabetes Care. 2016 Jun;39(6):893-901. doi: 10.2337/dc16-0145.
6
Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes.内镜下十二指肠黏膜重铺术治疗2型糖尿病
Dig Dis. 2018;36(4):322-324. doi: 10.1159/000487078. Epub 2018 Apr 20.
7
The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation.在常规化过程中,肠道微生物群会引起小鼠空肠黏膜的深刻代谢重定向。
Gut. 2013 Sep;62(9):1306-14. doi: 10.1136/gutjnl-2011-301955. Epub 2012 Jun 21.
8
Duodenal Mucosa: A New Target for the Treatment of Type 2 Diabetes.十二指肠黏膜:2型糖尿病治疗的新靶点。
Endocr Pract. 2023 Jan;29(1):53-59. doi: 10.1016/j.eprac.2022.10.177. Epub 2022 Oct 27.
9
Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.体重减轻与生活方式治疗、药物治疗和减重手术预防和治疗 2 型糖尿病:作用机制。
Curr Obes Rep. 2015 Jun;4(2):287-302. doi: 10.1007/s13679-015-0155-x.
10
Diabetes and branched-chain amino acids: What is the link?糖尿病与支链氨基酸:它们之间有何关联?
J Diabetes. 2018 May;10(5):350-352. doi: 10.1111/1753-0407.12645. Epub 2018 Feb 13.

引用本文的文献

1
Duodenal Laser Ablation for Treatment of Type 2 Diabetes: Results of First in Human Study.十二指肠激光消融术治疗2型糖尿病:首例人体研究结果
United European Gastroenterol J. 2025 Jun;13(5):750-758. doi: 10.1002/ueg2.12762. Epub 2025 Feb 20.
2
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease.十二指肠黏膜重建治疗非酒精性脂肪性肝病
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):166-169. doi: 10.1002/cld.1255. eCollection 2022 Nov.
3
Evolution of the diagnostic value of "the sugar of the blood": hitting the sweet spot to identify alterations in glucose dynamics.

本文引用的文献

1
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.GIPR 激动剂介导替西帕肽在肥胖小鼠中发挥不依赖体重的胰岛素增敏作用。
J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI146353.
2
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.水热十二指肠黏膜表面重建术治疗 2 型糖尿病患者的安全性和有效性:随机、双盲、假手术对照、多中心 REVITA-2 可行性试验。
Gut. 2022 Feb;71(2):254-264. doi: 10.1136/gutjnl-2020-323608. Epub 2021 Feb 17.
3
The metabolic impact of small intestinal nutrient sensing.
血糖的诊断价值演变:直击关键,识别葡萄糖动态变化。
Physiol Rev. 2023 Jan 1;103(1):7-30. doi: 10.1152/physrev.00015.2022. Epub 2022 May 30.
小肠营养感应的代谢影响。
Nat Commun. 2021 Feb 10;12(1):903. doi: 10.1038/s41467-021-21235-y.
4
Peripheral and central regulation of insulin by the intestine and microbiome.肠道和微生物群对胰岛素的外周和中枢调节。
Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E234-E239. doi: 10.1152/ajpendo.00547.2020. Epub 2020 Dec 14.
5
Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.双重 GIP 和 GLP-1 受体激动剂替西帕肽可改善 2 型糖尿病患者的β细胞功能和胰岛素敏感性。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):388-396. doi: 10.1210/clinem/dgaa863.
6
Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness.高正常范围的葡萄糖依赖性胰岛素促分泌肽与颈动脉内膜中层厚度增加有关。
Diabetes Care. 2021 Jan;44(1):224-230. doi: 10.2337/dc20-1318. Epub 2020 Nov 18.
7
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism.慢性葡萄糖依赖性胰岛素促分泌多肽受体(GIPR)激动剂作用脱敏可模拟功能性 GIPR 拮抗作用,使脂肪细胞 GIPR 活性降低。
Nat Commun. 2020 Oct 5;11(1):4981. doi: 10.1038/s41467-020-18751-8.
8
Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.十二指肠空肠旁路术可改善饮食诱导肥胖的肥胖症啮齿动物的非酒精性脂肪性肝病,而不依赖于体重减轻。
Am J Physiol Gastrointest Liver Physiol. 2020 Oct 1;319(4):G502-G511. doi: 10.1152/ajpgi.00357.2019. Epub 2020 Aug 19.
9
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study.内镜下十二指肠黏膜表面重建术治疗 2 型糖尿病:首个国际、开放标签、前瞻性、多中心研究的一年结果。
Gut. 2020 Feb;69(2):295-303. doi: 10.1136/gutjnl-2019-318349. Epub 2019 Jul 22.
10
Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.在葡萄糖耐量受损或新近诊断的 2 型糖尿病成人中停止药物干预后,β 细胞功能无持久改善。
Diabetes Care. 2019 Sep;42(9):1742-1751. doi: 10.2337/dc19-0556. Epub 2019 Jun 9.